Total Payments
$5,354
2024 Payments
$325.39
Companies
33
Transactions
384
Medicare Patients
8,142
Medicare Billing
$624,755
Payment Breakdown by Category
Food & Beverage$5,345 (99.8%)
Education$8.71 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,345 | 382 | 99.8% |
| Education | $8.71 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,048 | 71 | $0 (2024) |
| ABBVIE INC. | $903.90 | 59 | $0 (2024) |
| PFIZER INC. | $668.92 | 93 | $0 (2024) |
| GlaxoSmithKline, LLC. | $483.83 | 29 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $414.02 | 34 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $302.77 | 20 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $276.10 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $200.55 | 7 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $144.66 | 3 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $111.72 | 9 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $325.39 | 20 | ABBVIE INC. ($78.96) |
| 2023 | $803.65 | 51 | AbbVie Inc. ($275.08) |
| 2022 | $872.72 | 53 | ABBVIE INC. ($376.49) |
| 2021 | $610.93 | 44 | AbbVie Inc. ($173.37) |
| 2020 | $242.58 | 12 | Novo Nordisk Inc ($130.27) |
| 2019 | $329.50 | 47 | Novo Nordisk Inc ($152.38) |
| 2018 | $812.96 | 59 | Novo Nordisk Inc ($210.24) |
| 2017 | $1,356 | 98 | Janssen Pharmaceuticals, Inc ($262.56) |
All Payment Transactions
384 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $16.43 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/27/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.19 | General |
| Category: Cardiovascular | ||||||
| 04/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Cardiology | ||||||
| 03/14/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: ANTI-ANXIETY | ||||||
| 03/13/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Diabetes | ||||||
| 02/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: NEUROSCIENCE | ||||||
| 01/08/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/29/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX, AREXVY | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.60 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/12/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 764 | 1,924 | $249,704 | $112,140 |
| 2022 | 30 | 1,957 | 3,633 | $307,571 | $150,841 |
| 2021 | 39 | 2,722 | 6,247 | $385,563 | $196,050 |
| 2020 | 42 | 2,699 | 6,460 | $362,500 | $165,725 |
Total Patients
8,142
Total Services
18,264
Medicare Billing
$624,755
Procedure Codes
124
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 5 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17000 | Destruction of skin growth | Office | 2020 | 25 | 28 | $3,045 | $1,052 | 34.6% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 26 | 27 | $1,890 | $1,018 | 53.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 43 | 109 | $2,908 | $995.48 | 34.2% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 66 | 101 | $1,979 | $975.39 | 49.3% |
| 80076 | Liver function blood test panel | Office | 2020 | 82 | 116 | $1,958 | $940.20 | 48.0% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 41 | 41 | $779.00 | $779.00 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 47 | 48 | $1,380 | $740.05 | 53.6% |
| 81001 | Manual urinalysis test with examination using microscope | Office | 2020 | 102 | 219 | $1,430 | $690.81 | 48.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 56 | 69 | $1,806 | $685.05 | 37.9% |
| 72100 | X-ray of lower and sacral spine, 2 or 3 views | Office | 2020 | 27 | 31 | $1,908 | $649.40 | 34.0% |
| 82947 | Blood glucose (sugar) level | Office | 2020 | 63 | 159 | $1,344 | $620.07 | 46.1% |
| 73502 | X-ray of hip with pelvis, 2-3 views | Office | 2020 | 20 | 21 | $1,071 | $540.53 | 50.5% |
| G0179 | Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp | Office | 2020 | 15 | 18 | $1,080 | $453.43 | 42.0% |
| 73560 | X-ray of knee, 1 or 2 views | Office | 2020 | 19 | 19 | $1,015 | $315.30 | 31.1% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2020 | 19 | 19 | $855.00 | $303.00 | 35.4% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2020 | 13 | 16 | $832.00 | $279.54 | 33.6% |
| 71100 | X-ray of ribs of one side of body, 2 views | Office | 2020 | 12 | 14 | $812.00 | $270.98 | 33.4% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 16 | 70 | $748.00 | $232.51 | 31.1% |
| 72040 | X-ray of spine of neck, 2 or 3 views | Office | 2020 | 11 | 11 | $654.00 | $198.65 | 30.4% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 12 | 12 | $558.00 | $143.97 | 25.8% |
| 87210 | Smear for infectious agents | Office | 2020 | 12 | 21 | $220.00 | $121.26 | 55.1% |
| 87140 | Identification of organisms by immunologic analysis | Office | 2020 | 14 | 14 | $163.00 | $76.44 | 46.9% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2020 | 23 | 176 | $2,112 | $69.72 | 3.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2020 | 11 | 39 | $315.00 | $56.98 | 18.1% |
About Dr. Willard Burks, M.D
Dr. Willard Burks, M.D is a Family Medicine healthcare provider based in Wynne, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619082310.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Willard Burks, M.D has received a total of $5,354 in payments from pharmaceutical and medical device companies, with $325.39 received in 2024. These payments were reported across 384 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,345).
As a Medicare-enrolled provider, Burks has provided services to 8,142 Medicare beneficiaries, totaling 18,264 services with total Medicare billing of $624,755. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Wynne, AR
- Active Since 08/20/2006
- Last Updated 03/29/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1619082310
Products in Payments
- UBRELVY (Drug) $478.27
- Ozempic (Drug) $439.39
- QULIPTA (Drug) $357.07
- TRELEGY ELLIPTA (Drug) $332.73
- ELIQUIS (Drug) $317.86
- FARXIGA (Drug) $200.74
- CHANTIX (Drug) $195.85
- XARELTO (Drug) $189.93
- Victoza (Drug) $176.00
- Tresiba (Drug) $171.35
- JARDIANCE (Drug) $168.52
- GEMTESA (Drug) $158.89
- ENTRESTO (Drug) $144.66
- RYBELSUS (Drug) $142.74
- AREXVY (Drug) $123.75
- INVOKANA (Drug) $112.84
- Ranexa (Drug) $100.00
- LYRICA (Drug) $97.15
- Utibron (Drug) $95.50
- PREVNAR - 13 (Biological) $94.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wynne
Dr. Mark Bradshaw, M.d, M.D
Family Medicine — Payments: $5,627
Family Medicine $5,627
Dr. James Cathey, M.d, M.D
Family Medicine — Payments: $4,594
Family Medicine $4,594
Dr. James Beaton, M.d, M.D
Family Medicine — Payments: $3,374
Family Medicine $3,374
Sean Koch, Md, MD
Family Medicine — Payments: $3,138
Family Medicine $3,138
Jeremiah Nugent, M.d, M.D
Family Medicine — Payments: $2,336
Family Medicine $2,336
Mrs. Lesli Anderson, Aprn, APRN
Family Medicine — Payments: $390.90
Family Medicine $390.90